Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Sci Adv ; 7(6)2021 02.
Article in English | MEDLINE | ID: covidwho-1066791

ABSTRACT

Dysregulations in the inflammatory response of the body to pathogens could progress toward a hyperinflammatory condition amplified by positive feedback loops and associated with increased severity and mortality. Hence, there is a need for identifying therapeutic targets to modulate this pathological immune response. Here, we propose a single cell-based computational methodology for predicting proteins to modulate the dysregulated inflammatory response based on the reconstruction and analysis of functional cell-cell communication networks of physiological and pathological conditions. We validated the proposed method in 12 human disease datasets and performed an in-depth study of patients with mild and severe symptomatology of the coronavirus disease 2019 for predicting novel therapeutic targets. As a result, we identified the extracellular matrix protein versican and Toll-like receptor 2 as potential targets for modulating the inflammatory response. In summary, the proposed method can be of great utility in systematically identifying therapeutic targets for modulating pathological immune responses.


Subject(s)
COVID-19/pathology , Immunologic Factors/metabolism , Inflammation/pathology , Systems Biology/methods , COVID-19/immunology , COVID-19/virology , Cell Communication , Cytokines/genetics , Cytokines/metabolism , Humans , Immunity, Innate , Lymphocytes/cytology , Lymphocytes/immunology , Lymphocytes/metabolism , Receptors, Chemokine/genetics , Receptors, Chemokine/metabolism , SARS-CoV-2/isolation & purification , Severity of Illness Index , Toll-Like Receptor 2/antagonists & inhibitors , Toll-Like Receptor 2/metabolism , Versicans/antagonists & inhibitors , Versicans/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL